Submit Justification to study Tocilizumab in patients with giant cell arteritis: CDSCO Panel Tells Cipla Dr. Divya Colin30 Nov 2023 6:00 PM ISTNew Delhi: Reviewing the protocol presented by the drug major Cipla for the approval post-marketing active surveillance of Tocilizumab in patients of...
Medical Bulletin 10/November/2023 Isra Zaman10 Nov 2023 3:15 PM ISTHere are the top medical news of the day:Do allergic conditions increase the risk of developing Long-COVID after SARS-CoV-2 infection?In an analysis...
Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome Isra Zaman10 Nov 2023 9:30 AM ISTA recent study presented at ACR Convergence 2023 has offered newfound hope for individuals battling VEXAS syndrome, a rare and often lethal autoimmune...
Medical Bulletin 23/September/2023 Isra Zaman23 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Patients with severe psoriasis are at a higher risk for heart disease, study confirmsIn the largest study to...
European Commission grants approval to the first Tocilizumab biosimilar Isra Zaman23 Sept 2023 10:00 AM ISTThe European Commission has granted marketing authorization to Fresenius Kabi for its tocilizumab biosimilar, Tyenne. This marks the first approval of...
Tocilizumab biosimilar successfully meets primary, secondary endpoints in Phase I study: Dr Reddy's Labs Ruchika Sharma5 Jun 2023 2:00 PM ISTDr Reddy's is developing the proposed tocilizumab biosimilar as both intravenous and subcutaneous formulations.
CDSCO panel approves Reliance Life Science's Phase III CT Protocol for Tocilizumab Dr. Divya Colin9 April 2023 5:55 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved Reliance Life...
Use of exogenous sex hormones tied to more frequent remission in women with rheumatoid arthritis Dr. Kamal Kant Kohli24 March 2023 8:00 PM ISTAustralia: The use of oral contraceptives or hormone replacement therapy (HRT) is linked to a greater chance of remission in female rheumatoid...
CDSCO Panel allows Cipla to waive requirements for phase 4 study of tocilizumab inj for giant cell arthritis Dr. Divya Colin19 Jan 2023 6:00 PM ISTNew Delhi: Considering that Giant Cell Arthritis is very rare disease and there is challenge in recruitment of patients, the Subject Export Committee...
Roche Actemra gets USFDA okay to treat COVID in hospitalised adults Ruchika Sharma22 Dec 2022 11:15 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizumab) intravenous (IV) for the treatment of...
Tocilizumab biosimilar met primary, secondary endpoints in Phase 1 study: Dr Reddy's Labs Ruchika Sharma19 Dec 2022 5:14 PM ISTThe company is initiating a global Phase 3 study with the aim of comparing the efficacy, safety, tolerability and immunogenicity of DRL_TC with the...
Tocilizumab wins over Prednisone in Patients with Active Polymyalgia Rheumatica: JAMA Dr.Niharika Harsha B4 Oct 2022 12:00 PM ISTTocilizumab usage in active polymyalgia rheumatica patients resulted in a polymyalgia rheumatica activity score computed using the C-reactive protein...
